Earnings Ahead

CYCC - Cyclacel Pharmaceuticals, Inc.

0.5819 -0.0082 -1.39

Cyclacel Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc.

About

Profile


Headquarters

Berkeley Heights, New Jersey, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

CYCC



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Cyclacel Pharmaceuticals GAAP EPS of -$0.47 beats by $0.19
  • Cyclacel Pharmaceuticals Q1 2023 Earnings Preview
  • Cyclacel Pharmaceuticals receives $4.7M R&D tax credit
  • Cyclacel Pharmaceuticals GAAP EPS of -$0.60 misses by $0.12
  • Cyclacel Pharmaceuticals GAAP EPS of -$0.42 beats by $0.14
  • Cyclacel Pharmaceuticals Q3 2022 Earnings Preview
  • Cyclacel stock rises 16% as net loss narrows, income grows
  • Cyclacel Pharmaceuticals GAAP EPS of -$0.46 beats by $0.08, revenue of $0M
  • Cyclacel Pharmaceuticals Q2 2022 Earnings Preview
  • Cyclacel Pharmaceuticals GAAP EPS of -$0.42 beats by $0.27
  • Cyclacel Pharmaceuticals Q1 2022 Earnings Preview
  • Cyclacel Pharmaceuticals jumps on preclinical data for blood cancer treatment fadraciclib
  • Cyclacel Pharmaceuticals GAAP EPS of -$1.34
  • Cyclacel Pharmaceuticals Q4 2021 Earnings Preview
  • Catalyst watch for next week: Biogen, Five Below, Tritium and Monster Beverage in the spotlight
  • Cyclacel Pharmaceuticals reveals plans for cancer drug programs for 2022
  • Cyclacel Pharmaceuticals EPS beats by $0.23
  • Cyclacel Pharmaceuticals Q3 2021 Earnings Preview
  • Cyclacel gets dosing underway in phase 1/2 oral fadraciclib study
  • Cyclacel Pharmaceuticals EPS misses by $0.07
PEERS
/XLV

XLV

Earnings History

Date EPS / Forecast Revenue / Forecast
November 10, 2021 -0.54 / -0.7 - / -
August 11, 2021 -0.56 / -0.51 - / -
May 12, 2021 -0.5 / -0.4867 - / -
February 25, 2021 -1.34 / -0.53 - / -
November 11, 2020 -0.47 / -0.55 - / -
August 12, 2020 -0.58 / -0.47 - / -
May 19, 2020 - / -3 - / -
March 31, 2020 - / -0.14 - / -
February 26, 2020 -2.8 / -0.14 - / - Beat!
November 18, 2019 - / -0.16 - / -
August 13, 2019 -0.11 / -0.16 - / -
May 14, 2019 -0.14 / -0.21 - / -
March 27, 2019 -0.16 / -0.17 200K / - Beat!
November 12, 2018 -0.18 / -0.17 150.0K / - Beat!
August 9, 2018 -0.16 / -0.12 150.0K / - Beat!
May 14, 2018 -0.12 / -0.13 150.0K / - Beat!
August 9, 2017 - / - 0.22M / - Beat!
May 10, 2017 - / - - / -
March 28, 2017 -0.69 / - 277.0K / 424.0K
November 14, 2016 -0.86 / -0.89 205.0K / - Beat!
August 10, 2016 - / -0.94 222.0K / - Beat!
May 11, 2016 - / - 139.0K / - Beat!
Date Price Open High Low Vol Change ER
Mar 17 3.020 2.810
3.035
2.810
30.01K 6.71%
Mar 16 2.830 2.720
2.880
2.720
11.83K 4.43%
Mar 15 2.710 2.770
2.770
2.629
16.84K -2.87%
Mar 14 2.790 2.920
2.940
2.770
21.83K -5.1%
Mar 11 2.940 2.960
2.990
2.770
40.82K -3.92%
 
Mar 10 3.060 3.100
3.300
2.980
41.56K -7.55%
Mar 9 3.310 3.240
3.450
3.088
74.45K 0.30%
Mar 8 3.300 3.000
3.300
3.000
28.33K -0.6%
Mar 7 3.320 3.500
3.545
3.290
42.27K -5.14%
Mar 4 3.500 3.400
3.670
3.371
50.17K 2.94%
Mar 3 3.400 3.390
3.500
3.180
52.03K -0.58%
Mar 2 3.420 3.380
3.620
3.160
69.98K 0.59%
Mar 1 3.400 3.340
3.500
3.275
42.46K 4.62%
Feb 28 3.250 3.214
3.380
3.214
13.94K -2.99%
Feb 25 3.350 3.500
3.840
3.243
35.33K 5.02%
Feb 24 3.190 3.040
3.330
2.880
72.39K -0.93%
Feb 23 3.220 3.350
3.370
3.151
30.70K -4.73%
Feb 22 3.380 3.330
3.380
3.254
15.94K 0.59%
Feb 18 3.360 3.589
3.740
3.320
41.52K -9.19%